Literature DB >> 5412706

Large glucagon immunoreactivity in extracts of pancreas.

D Rigopoulou, I Valverde, J Marco, G Faloona, R H Unger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5412706

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  31 in total

1.  Plasma glucagon immunoreactivity in a totally pancreatectomized patient.

Authors:  M L Villanueva; J A Hedo; J Marco
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

3.  Synthesis of proinsulin and large glucagon immunoreactivity in isolated Langerhans islets from EMC-virus infected mice.

Authors:  K G Petersen; P Heilmeyer; L Kerp
Journal:  Diabetologia       Date:  1975-02       Impact factor: 10.122

4.  The purification and biological properties of pancreatic big glucagon.

Authors:  K J O'Connor; N R Lazarus
Journal:  Biochem J       Date:  1976-05-15       Impact factor: 3.857

5.  Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.

Authors:  S F Kuku; J B Jaspan; D S Emmanouel; A Zeidler; A I Katz; A H Rubenstein
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

6.  The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth.

Authors:  F Jockenhövel; S Lederbogen; T Olbricht; H Schmidt-Gayk; E P Krenning; S W Lamberts; D Reinwein
Journal:  Clin Investig       Date:  1994-01

7.  Glucagon effects on the human small intestine.

Authors:  G K Patel; G E Whalen; K H Soergel; W C Wu; R C Meade
Journal:  Dig Dis Sci       Date:  1979-07       Impact factor: 3.199

8.  Processing of enkephalin-containing peptides in isolated bovine adrenal chromaffin granules.

Authors:  G Fleminger; E Ezra; D L Kilpatrick; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Glucagon metabolism in the rat.

Authors:  D S Emmanouel; J B Jaspan; A H Rubenstein; A H Huen; E Fink; A I Katz
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.

Authors:  W A Muller; L Girardier; J Seydoux; M Berger; A E Renold; M Vranic
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.